Incidence and significance of hepatitis B e antigen and antibody in postnecrotic cirrhosis and primary hepatocellular carcinoma.
AUTOR(ES)
Coursaget, P
RESUMO
A study of the serological markers of Hepatitis B virus (HBV) including e antigen (HBe Ag) and antibody against HBe Ag (anti-HBe) was performed in Senegalese patients suffering from cirrhosis and primary hepatocellular carcinoma, and in a control group (blood donors). It was not possible to diagnose additional HBV infections in primary hepatocellular carcinoma patients using HBe Ag or anti-HBe Ab alone as serological markers. The lower prevalence of HBe Ag among primary hepatocellular carcinoma patients as compared with cirrhotic patients suggests that active replication of HBV becomes increasingly defective during the course of the malignant process.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=274975Documentos Relacionados
- Myofibroblasts in hepatitis B related cirrhosis and hepatocellular carcinoma.
- Hepatitis B virus infection and primary hepatocellular carcinoma.
- Incidence in South-west Scotland of hepatitis B surface antigen in the liver of patients with hepatocellular carcinoma.
- Aetiology of cirrhosis, hepatic fibrosis, and hepatocellular carcinoma.
- Integrated structures of duck hepatitis B virus DNA in hepatocellular carcinoma.
